Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 110.22 USD 1.68% Market Closed
Market Cap: 21.9B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Zimmer Biomet Holdings Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zimmer Biomet Holdings Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Zimmer Biomet Holdings Inc
NYSE:ZBH
Total Current Assets
$4.9B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
1%
Becton Dickinson and Co
NYSE:BDX
Total Current Assets
$10.5B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Total Current Assets
$8.8B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Total Current Assets
$14.7B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
5%
Abbott Laboratories
NYSE:ABT
Total Current Assets
$23.1B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Assets
$7.2B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
16%
No Stocks Found

Zimmer Biomet Holdings Inc
Glance View

Market Cap
22B USD
Industry
Health Care

Zimmer Biomet Holdings Inc. is a leading global medical device company renowned for its innovative solutions in the musculoskeletal health sector. Founded in 1927 and headquartered in Warsaw, Indiana, the company specializes in orthopedic implants, including those used in joint reconstruction and spinal surgery, as well as dental and neuromuscular devices. With a commitment to enhancing the quality of life for patients worldwide, Zimmer Biomet leverages cutting-edge technology and extensive research to develop products that cater to an aging population and a growing demand for minimally invasive surgical options. As the healthcare landscape evolves, Zimmer Biomet’s adaptable business strategy and focus on strategic partnerships position it favorably to capture new market opportunities and drive future growth. For investors, Zimmer Biomet represents a compelling choice within the healthcare sector due to its strong market presence and consistent revenue generation. The company operates in a resilient industry characterized by ongoing technological advancements and a steady demand for orthopedic procedures driven by demographic trends. Zimmer Biomet has strategically streamlined its operations, enhancing operational efficiencies and reducing costs, which are promising signs of financial health. With a robust pipeline of innovative products and a focus on expanding its global footprint, Zimmer Biomet is well-equipped to navigate the complexities of the healthcare market and deliver sustainable value to its shareholders over the long term.

ZBH Intrinsic Value
153.21 USD
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Zimmer Biomet Holdings Inc's Total Current Assets?
Total Current Assets
4.9B USD

Based on the financial report for Sep 30, 2024, Zimmer Biomet Holdings Inc's Total Current Assets amounts to 4.9B USD.

What is Zimmer Biomet Holdings Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
1%

Over the last year, the Total Current Assets growth was 11%. The average annual Total Current Assets growth rates for Zimmer Biomet Holdings Inc have been -3% over the past three years , 2% over the past five years , and 1% over the past ten years .

Back to Top